1. Bruggink-André de la Porte PWF ISBN : Effects of heart failure management programmes Promotiedatum: 16 januari 2009

Transcription

1 Publicaties 2009 Dissertaties Bruggink-André de la Porte PWF ISBN : Effects of heart failure management programmes Promotiedatum: 16 januari 2009 Promotores: Prof.dr. A.W. Hoes Prof.dr. D.J. van Veldhuisen 2. Loef BG Acute kidney injury after cardiac surgery. Impact on long-term outcome and target for intervention ISBN: Promotiedatum: 21 januari 2009 Promotores: Prof.dr. T. Ebels Copromotores: Prof.dr. G.J. Navis Dr. A.H. Epema Dr. C.A. Stegeman 3. Broers CJM De Nurse Practitioner; verpleegkundig specialist tussen care en cure ISBN: Promotiedatum: 8 april 2009 Promotor: Co-promotores: Prof.dr. D.J. van Veldhuisen Dr. T. Jaarsma Dr. V.A.W.M. Umans 4. Damman K Cardiorenal interaction in heart failure. ISBN: ISBN Elektronische versie: Promotiedatum: 22 april 2009 Promotores: Prof.dr. J.L. Hillege Prof.dr. D.J. van Veldhuisen Prof.dr. G. Navis Copromotor: Dr. A.A. Voors 5. Piers LH Computed tomography for the evaluation of the aortic valve and coronary arteries ISBN: Promotiedatum: 17 juni 2009 Promotor: Prof.dr. F. Zijlstra Copromotor: Dr. R.A. Tio 6. Buck S Optimization of cardiac resynchronization therapy in atrial fibrillation and sinus rhythm ISBN: Promotiedatum: 4 november 2009 Promotores: Prof.dr. I.C. van Gelder Prof.dr. D.J. van Veldhuisen

2 Copromotor: Dr. A.H. Maass 7. Van der Vleuten PA Left ventricular function after STEMI. Developments in diagnostics and cell therapy ISBN: ISBN (digital): Promotiedatum: 16 december 2009 Promotor: Prof.dr. F. Zijlstra Copromotor: Dr. R.A. Tio

3 Publicaties 2009 Internationale tijdschriften Petrie CJ, Voors AA, Van Veldhuisen DJ Low pulse pressure is an independent predictor of mortality and mobidity in non ischaemic, but not in ischaemic advanced heart failure patients. Int. J. Cardiol 2009;131: Jaarsma T, Arestedt KF, Märtensson J, Dracup K, Strömberg A The European Heart Failure Self-care Behaviour scale revised into a nine-item scale (EHBFScB-9): a reliable and valid international instrument. Eur J Heart Fail 2009;11: Westendorp B, Hamming I, Szymanski MK, Navis G, Van Goor H, Buikema H, Van Gilst WH, Schoemaker RG Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor. Eur J Pharmacol 2009;602:373-9 Belonje AM, Westenbrink BD, Voors AA, Von Haehling A, Ponikowski P, Anker SD, Van Veldhuisen DJ, Dickstein K Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan. Am Heart J 2009;157:91-6 Oeseburg H, Iusuf D, Van der Harst P, Van Gilst WH, Henning RH, Roks AJ Bradykinin protects against oxidative stress-induced endothelial cell senescence. Hypertension 2009;53: Meerwaldt R, Slart RH, Van Dam GM, Luijckx GJ, Tio RA, Zeebregts CJ PET/SPECT imaging: From carotid vulnerability to brain viability. Eur J Radiol 2009; Dasselaar JJ, Slart RH, Knip M, Pruim J, Tio RA, McIntyre CW, De Jong PE, Franssen CF Haemodialysis is associate with a pronounced fall in myocardial pefusion. Nephrol Dial Transplant 2009;24: Ruifrok WP, De Boer RA, Iwakura A, Silver M, Kusano K, Tio RA, Losordo DW Estradol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia Vasc Med 2009;14:29-36 Altena R, De Haas EC, Nuver J, Brouwer CAJ, Van den Berg MP, Smit AJ, Postma A, Sleijfer, Gietema JA Evaluation of sub-acute changfes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer. Brit J Cancer 2009;100: Sochalski J, Jaarsma T, Krumholz HM, Laramee A, McMurray JJ, Naylor MD, Rich MW, Riegel B, Stewart S What works in chronic care management: the case of heart failure. Health AA (Milwood) 2009;28:179-89

4 Glaudemans AW, Slart RH, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BP, Dierckx RA Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging 2009;36: Holm PA, Slart RH, Zeebregts CJ, Hillebrands JL, Tio RA Atherosclerotic plaque development and instability: a dual role for VEGF. Ann Med 2009;41: Waanders F, Vaidya VS, Van Goor H, Leuvenink H, Damman K, Hamming I, Bonventre JV, Vogt L, Navis G Effect of rennin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Am J Kidney Dis 2009;53:15-25 Van Melle JP, De Jonge P Beta-blocker use and the development of depression. Am J Cardiol 2009;103: Oeseburg H, Iusuf D, Van der Harst P, Van Gilst WH, Henning RH, Roks AJ Bradykinin protects against oxidative stress-induced endothelial cell senescence. Hypertension 2009;53: De Smedt RH, Denig P, Haaijer-Ruskamp FM, Jaarsma T Perceived medication adverse effects and coping strategies reported by chronic heart failure patients. Int J Clin pract 2009;63: CRT Survey Scientific Committee European cardiac resynchronization therapy survey, rationale and design. Eur J Heart Fail 2009;11: Jaarsma T, Fridlund B, Stromberg A, Thompson DR The European Journal of Cardiovascular Nursing. Eur J Cardiovasc Nurs 2009;8:1 Wong LS, Oeseburg H, De Boer RA, Van Gilst WH, Van Veldhuisen DJ, Van der Harst P Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and Ageing. Cardiovasc Res 2009;81: Annema C, Luttik ML, Jaarsma T Do patients with heart failure need a casemanager? J Cardiovasc Nurs 2009;24: Otterman ML, Nijboer JM, Van der Horst IC, Van Meurs M, Ten Duis HJ, Nijsten MW Reticulocyte counts and their relation to hemoglobin levels in trauma patients. J Trauma 2009;67:121-4 Winter NN, Bouma BJ, Groenink M, Konings TC, Tijssen JG, Van Veldhuisen DJ, Mulder BJ Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart 2009;95:960-3 Tulner DM, Smith OR, De Jonge P, Van Melle JP, Slomp J, Stork H, Queré M, Den Boer JA, Honing A, Korf J

5 Circulating cerebral S100B protein is associated with depressive symptoms following myocardial infarction. Neuropsychobiology 2009;59:87-95 Smilde TD, Damman K, Van der Harst P, Navis G, Westenbrink DB, Voors AA, Boomsma F, Van Veldhuisen DJ, Hillege HL Differential associations between renal function and modifiable risk factors in patients with chronic heart failure. Clin Res Cardiol 2009;98:121-9 Smilde TD, Van Veldhuisen DJ, Van den Berg MP Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure. Clin Res Cardiol 2009;98:233-9 Damman K, Van Deurssen VM, Navis G, Voors AA, Van Veldhuisen DJ, Hillege HL Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009;53:582-8 Lesman-Leegte I, Jaarsma T, Coyne JC, Hillege HL, Van Veldhuisen DJ, Sanderman R Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls. J Card Fail 2009;15:17-23 Damman K, Van Veldhuisen DJ, Hillege HL Cardiac resynchronization therapy improves renal function: importance of forward and backward failure. J Card Fail 2009;15:78-9 Altena R, Perik PJ, Van Veldhuisen DFJ, De Vries EG, Gietema JA Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncol 2009;10:391-9 Van Melle JP, De Jonge P Beta-blocker use and the development of depression. Am J Cardiol 2009;103: Al-Ansari S, Zeebregts CJ, Slart RH, Peppelenbosch M, Tio RA Galectins in atherosclerotic disease. Trends Cardiovasc. Med 2009;19:164-9 Van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD; SENIORS Investigators Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction. Data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure. J Am Coll Cardiol 2009;53: Voors AA, Von Haehling S, Anker SD, Hillege HL, Struck J, Hartmann O, Bergmann A, Squire I, Van Veldhuisen DJ, Dickstein K; OPTIMAAL Investigators

6 C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAl Study. Eur Heart J 2009;30: Smid MD, Van Gelder IC, Böhm M, Neuberger HR, Van Veldhuisen DJ Should aldosterone blockade be uased beyong current indications in heart failure? Curr Heart Fail Rep 2009;6: Van der Roest WP, Pennings JM, Bakker M, Van den Berg MP, Van Tintelen JP Family letters are an effective way to inform relatives about inherited cardiac disease. Am J Med genet A 2009;149A: Wong LS, Van der Harst P, De Boer RA, Codd V, Huzen J, Samani NJ, Hillege HL, Voors AA, Van Gilst WH, Jaarsma T, Van Veldhuisen DJ Renal dysfunction is associated with shorter telomere length in heart failure. Clin Res Cardiol 2009 Linssen GC, Damman K, Hillege HL, Navis G, Van Veldhuisen DJ, Voors AA Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure. Circulation 2009;120:35-41 Ghali JK, Wikstrand J, Van Veldhuisen DJ, Fagerberg B, Goldstein S, Hjalmarson A, Johansson P, Kjekshus J, Ohlsson L, Samuelsson O, Waagstein F, Wedel H; MERIT-HF Study Group The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF). J Card Failure 2009;15:310-8 Denollet J, De Jonge P, Kuyper A, Schene AH, Van Melle JP, Ormel J, Honig A Depression and Type D personality represent different forms of distress in the Myocard INfarction and Depression-Intervention Trial (MIND-IT). Psychol Med 2009;39: Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristenses SD, McGregor K, Sechtern U, Silber S. Tendera M, Widimsky P, Zamorano JL, Auricchio A, Bax J, Böhm M, Corrà U, Della Bella P, Elliott PM, Follath F, Gheorghiade M, Hasin Y, Hernborg A, Jaarsma T, Komajda M, Kornowski R, Piepoli M, Prendergast B, Tavazzi L, Vachiery JL, Verheugt FW, Zannad F; Task Force per la Diagnosi e il Trattamento dello Scompenso Cardiaco Acute e Cronico 2008 della Società Europea di Cardiologia Guidelines for the diagnosis and treatment of acute and chronic heart failure G Ital Cardiol (Rome) 2009;10: Savva J, Maqbool A, White HL, Galloway SL, Yuldasheva NY, Ball SG, West RM, De Boer RA, Van Veldhuisen DJ, Balmforth AJ; Merit-HF Study Group Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy. J Card Fail 2009;15: Tio RA, Dabeshlim A, Siebelink HMJ, De Sutter J, Hillege HL. Zeebregts CJ, Dierckx RAJO, Van Veldhuisen DJ, Zijlstra F, Slart RHJA Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease.

7 J Nucl Med 2009;50: Hartong DT, McGee TL, Sandberg MA, Berson EL, Asselbergs FW, Van der Harst P, De Vivo I, Dryja TP Search for a correlation between telomere length and severity of retinitis pigmentosa due to the dominatn rhodopsin Pro23His mutation. Mol Vis 2009;15:592-7 Van Veldhuisen DJ, De Boer RA Low-dose digoxin in heart failure, Int J Cardiol 2009:136:90-1; author reply 91-2 Wallis de Vries BM, Hillebrands JL, Van Dam GM, Tio RA, De Jong JS, Slart RH, Zeebregts CJ Images in cardiovascular medicine. Multrispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe. Circulation 2009;119:e534-6 Piers LJ, Touw HR, Gansevoort R, Franssen CF, Oudkerk M, Zijlstra F, Tio RA Relation of aortic valve and coronary artery calcium in patients with chronic kidney disease to the stage and etiology of the renal disease. Am J Cardiol 2009;103: De Vita M, Burzotta F, Biondi-Zoccai, Lefevre T, Dudek D, Antoniucci D, Orrego PS, De Luca L, Kaltoft A, Sardella G, Zijlstra F, Isshiki T, Crea F Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: a pooled Analysis of trials on ThrombEctomy in acute Myocaridal infarction based on individual PatienT data. Vasc Health Risk Manag 2009;5:243-7 Pons D, Monraats PS, Zwinderman AH, De Maat MP, Doevendans PA, De Winter RJ, Tio RA, Waltenberger J, Jukema JW Metabolic background determines the importance of NOS3 polymorphisms in restenosis after percutaneous coronary intervention. A study in patients with and without the metabolic syndrome. Dis Markers 2009;26:75-83 Smit JJJ, Van Oeveren W, Ottervanger JP, Slingerland RJ, Remijn JA, Zijlstra F, Van t Hof AWJ Iron-induced platelet aggregation measurement: a novel method to measure platelet function in stenting for ST elevation myocardial infarction. Eur J Clin Invest 2009;39:103-9 Willemsen HM, De Jong G, Tio RA, Nieuwland W, Kema IP, Van der Horst IC, Oudkerk M, Zijlstra F Quick identification of acute chest pain patients study (QICS). BMC Cardiovasc Disord 2009;9:24 Vogelzang M, Vlaar PJ, Svilaas T, Amo D, Nijsten MW, Zijlstra F Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial Eur Heart J 2009;30:594-9

8 Van der Vleuten PA, Vogelzang M, Svilaas T, Van der Horst IC, Tio RA, Zijlstra F Predictive value of Q waves on the 12-lead electrocardiogram after reperfusion therapy for ST elevation myocardial infarction. J Electrocardiol 2009;42:310-8 Dieperink W, Weelink EE. Van der Horst IC, De Vos R, Jaarsma T, Aarts LP, Zijlstra F, Nijsten MW Treatment of presumed acute cardiogenic pulmonary oedema in an ambulance system by nurses using Boussignac continuous positive airway pressure Emerg Med J 2009;26:141-4 De Boer RA, Van der Harst P, Van Veldhuisen DJ, Van den Berg MP Pharmacogenetics in heart failure: promises and challenges. Expert Opin Pharmacother 2009;10: Zijlstra F The benefits and risks of abciximab, eptifibatide, or tirofiban during PCI: class effects or do they differ? Catheter Cardiovasc Interv 2009;73:222-3 Groen JM, Van der Vleuten PA, Greuter MJ, Zijlstra F, Oudkerk M Comparison of MRI, 64-slide MDCT and DSCT in assessing functional cardiac parameters of a moving heart phantom Eur Radiol 2009;19: Van der Vleuten PA, De Jonge GJ, Lubbers DD, Tio RA, Willems TP, Oudkerk M, Zijlstra F Evaluation of global left ventricular function assessment by dual-source computed tomography compared with MRI Eur Radiol 2009;19:271-7 Althena R, De Haas EC, Nuver J, Brouwer CA, Van den Berg MP, Smit AJ, Postma A, Sleijfer DT, Gietema JA Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer. Br J Cancer 2009;100: Van der Zwaag PA, Jongbloed JD, Van den Berg MP, Jonkman MF, Van Tintelen JP Letter regarding the article R298Q mutation of p63 gene in autosomal dominant ectodermal dysplasia associated with arrhthmogenic right ventricular cardiomyopathy, by Valenzise et al. Eur J Med Genet 2009;52:277 Van den Berg MP, De Boer RA, Van Tintelen JP Brugada syndrome or Brugada electrocardiogram? J Am Coll Cardiol 2009;53:1569; author reply Dierckx B, Tulen JH, Van den Berg MP, Tharner A, Jaddoe VW, Moll HA, Hofman A, Verhulst FC, Tiemeier H Maternal psychopathology influences infant heart rate variability: Generation R Study Psychosom Med 2009;71: Peels JO, Hautvast RW, De Swart JB, Huybregts MA, Umans VA, Arnold AE, Jessurun GA, Zijlstra F Percutaneous coronary intervention without on site surgical back-up; two-years registry of a large Dutch community hospital Int J Cardiol 2009;132:59-65

9 Fokkema ML, Van der Vleuten PA, Vlaar PJ, Svilaas T, Zijlstra F Incidence, predictors, and outcome of reinfarction and stent thrombosis within one year after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Catheter Cardiovasc Interv 2009;73: Tan ES, Jessurun GA, Anthonio RL, Slart RH, Zijlstra F, Tio RA Electromechanical mapping of the left ventricle: possible tool for online decision making in the catheterization laboratory. J Cardiovasc Med (Hagerstown) 2009;10:415-9 Fokkema ML, Vlaar PJ, Svilaas T, Vogelzang M, Amo D, Diercks GF, Suurmeijer AJ, Zijlstra F Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J 2009;30: Ahmed S, Crijns HJGM, Van Gelder IC Treatment with Amiodarone to prevent atrial fibrillation, reply. JAMA 2009;301:1020 Smit MD, Van Gelder IC Is inflammation a risk factor for recurrent atrial fibrillation? Europace 2009;11:138-9 Newton-Cheh C, Johnson T, Gateva V,., van der Harst P,. Abecasis GR, Caulfield M, Munroe PB. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009;41: Trégouët D, König IR, Erdmann J,., van der Harst P,., Cambien F, Schunkert H, Samani NJ. A genomewide haplotype association study identifies the SLC22A3/LPAL2/LPA gene cluster as a strong susceptibility locus for coronary artery disease. Nat Genet 2009;41: Loef, BG, Epema AH, Navis G, Ebels T, Stegeman CA Postoperative renal dysfunction and preoperative left ventricular dysfunction predispose patients to increased long-term mortality after coronary artery bypass graft surgery. Br J Anaesth 2009;102: Douglas YL, Jongbloed MR, Den Hartog WC, Bartelings MM, Bogers AJ, Ebels T, De Ruiter MC, Gittenberger-de Groot AC Pulmonary vein and atrial wall pathology in human total anomalous pulmonary venous connection. Int J Cardiol 2009;134: Douglas YL, Mahtab EA, Jongbloed MR, Uhrin P, Zaujec J, Binder BR, Schalij MJ, Poelmann RE, De Ruiter MC, Gittenberger-De Groot AC Pulmonary vein, dorsal atrial wall and atrial septum abnormalities in podoplanin knockout mice with disturbed posterior heart field contribution. Pediatr Res 2009;65:27-32 Maass AH, Waterbolk TW, Van Gelder IC Pitfalls of internal cardioverter defibrillator implantation: part I Europace 2009;11:237-8

10 Maass AH, Waterbolk TW, Van Gelder IC Pitfalls of internal cardioverter defibrillator implantation: part II Europace 2009;11: Hartog JW, Willemensen S, Voors AA Letter by Hartog et al, regarding article Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines. Circulation 2009;119:e223; author reply e234 Vermeijden JW, Zijlstra JG, Erasmus ME, Van der Bij W, Verschuuren EA Lung transplantation for ventilator-dependent respiratory failure J Heart Lung Transplant 2009;28: Van der Zwaag PA, Jongbloed JD, Van den Berg MP, Van der Smagt JJ, Jongbloed R, Bikker H, Hofstra RM, Van Tintelen A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy Hum Mutat 2009 Van den Berg MP, Van der Ende J, Crijnen AA, Jaddoe VW, Moll HA, Mackenbach JP, Hofman A, Hengeveld MW, Tiemeier H, Verhulst FC Paternal depressive symptoms during pregnancy are related to excessive infant crying. Pediatrics 2009;124:e Deuling JH, Smid MD, Maass AH, Van den Heuvel AF, Nieuwland W, Zijlstra F, Van Gelder IC The value and limitations of a wound inspection clinic after cardiac device implantation. Eur J Cardiovasc Nurs 2009;8: Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomized, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 2009;373: Al-Anari S, Zeebregts CJ, Slart RH, Peppelenbosch M, Tio RA Galectins in atherosclerotic disese. Trends Cardiovasc Med 2009;19:164-9 Anker SD, Voors A, Okonko D, Clark AL, James MK, Von Haehling S, Kjekshus J, Ponikowski P, Dickstein K; OPTIMAAL Investigators Prevalence, indicidence, and prognostic value of anaemia in patients aftera n acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J 2009;30: Maass AH, Buck S, Nieuwland W, Brügemann J. Van Veldhuisen DJ, Van Gelder IC Importance of heart rate during exercise for response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2009;20: Luttik ML, Jaarsma T, Lesman I, Sanderman R, Hagedoorn M Quality of life in partners of people with congestive heart failure gender and involvement of care. J Adv Nurs 2009;65:

11 Jaarsma T, beattle JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, Murray SA, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker SD, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J; Advanced Heart Failure Study Group of the HFA of the ESC Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11: Smid MD, Van Gelder IC Upstream therapy of atrial fibrillation Expert Rev Cardiovasc Ther 2009;7: Maass AH, Van Gelder IC Hazards of antitachycardia pacing to treat ventricular tachycardias with implantable cardioverter Defibrillators. Europace 2009;11:819 Smid MD, Van Gelder IC Will we be able to predict in which atrial fibrillation patients a rhythm control strategy will be succesfull? Europace 2009;11:846-7 Lazarenko SV, Van der Vleuten PA, Tio RA, Willemsen AT, Paans AM, Douma JE, Zeebregts CJ, Dierckx RA, Zijlstra F, Slart RH Left ventricular volume assessment by planar radionuclide ventriculography evaluated by MRI. Nucl Med Commun 2009;30: Smit MD, Van Gelder IC, Böhm M, Neuberger HR, Van Veldhuisen DJ Should aldosterone blockade be used beyond current indications in heart failure? Curr Heart Fail Rep 2009;6: De Boer RA, Van der Harst P, Van Veldhuisen DJ, Van den Berg MP Pharmacogenetics in heart failure: promises and challenges. Expert Opin Pharmacother 2009;10: Gnecchi M, He H, Melo LG, Noiseaux N, Morello F, De Boer RA, Zhang L, Pratt RE, Dzau VJ, Ingwall JS Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 2009;27:971-9 Backlund M, Paukku K, Daviet L, De Boer RA, Valo E, Hautaniemi S, Kalkkinen N, Ehsan A, Kontula KK, Lehtonen JY Posttransscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3- phosphate dehydrogenase. Nucleic Acids Res 2009;37: Van der Meer P, Groenveld HF, Januzzi JL Jr., Van Veldhuisen DJ Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart 2009;95: Van der Meer P, Van Veldhuisen DJ Anaemia and renal dysfunction in chronic heart failure. Heart 2009;95:

12 Van der Zwaag PA, Jongbloed JD, Van den Berg MP, Van der Smagt JJ. Jongbloed R, Bikker H, Hofstra RM, Van Tintelen JP A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Hum Mutat 2009;30: McMurray JJ, Anand IS, Diaz R, Maggioni AP, OÇonnor C, Pfeffer MA, Polu KR, Solomon SD, Sun Y, Swedberg K, Tendera M, Van Veldhuisen DJ, Wasserman SM, Young JB; RED-HF Committees and Investigators Design of the reduction of events with carbepoetin alfa in heart failure (RED-HF): a phase III, anaemia correction, morbidity-tmortality trial Eur J Heart Fail 2009;11: De Boer RA, Voors AA, Muntendam P, Van Gilst WH, Van Veldhuisen DJ Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail 2009;11:811-7 Cohen-Solal A, Kotecha D, Van Veldhuisen DJ, Babalis D, Böhm M, Coats AJ, Roughton M, Poole-Wilson P, Tavazzi L, Flather M; SENIOR Investigators. Eur J Heart Fail 2009;11: Wong LS, Van der Hart P, De Boer RA, Codd V, Huzen J, Samani NJ, Hillege HL, Voors AA, Van Gilst WH, Jaarsma T, Van Veldhuisen DJ Renal dysfunction is associated with shorter telomere length in heart failure. Clin Res Cardiol 2009;98: Bessem B, Groot FP, Nieuwland W The Lausanne recommendations: a Dutch experience. Br J Sports Med 2009; Willemsen HM, Van der Horst IC, Nieuwland W, Slart RJ, Zeebregts CJ, De Boef E, Schuitemaker JH, Zijlstra F, Tio RA The diagnostic value of soluble CD163 in patients presenting with chest pain. Clin Biochem 2009;42: Lexis CP, Rahel BM, Meeder JG, Zijlstra F, Van der Horst IC The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus. Cardiovasc Diabetol 2009;8:41 Rasoul S, Ottervanger JP, De Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Zijlstra F, Suryapranata H, Van t Hof AW; Zwolle Myocardial Infarction Study Group Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for STelevation myocardial infarction. Coron Artery Dis 2009;20: Slart RH, Tio RA, Zijlstra F, Dierckx Diagnostic pathway of integrated SPECT/CT for coronary artery disease Eur J Nucl Med Mol Imaging 2009;36: Vlaar PJ, Zijlstra F Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation. JACC Cardiovasc Interv 2009;776-8

13 Halbersma WB, Arrigoni SC, Mecozzi G, Grandjean JG, Kappetein AP, Van der Palen J, Zijlstra F, Mariani MA Four-year outcome of OPCAB no-touch with total arterial Y-graft: making the best treatment a daily practice Ann Thorac Surg 2009;88: Rasoul S, Ottervanger JP, De Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Zijlstra F, Suryapranata H, van t Hof AW, Zwolle Myocardial Infarction Study Group Primary percutaneous coronary intervention for ST-elevation myocardial infarction: from clinical trial to clinical practice. Int J Cardiol 2009;134:104-9 Nijveldt R, Van der Vleuten PA, Hirsch A, Beek AM, Tio RA, Tijssen JG, Piek JJ, Van Rosssum AC, Zijlstra F, Van Gelder IC Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size. JACC Cardiovasc Imaging 2009;2: Gu YL, Fokkema ML, Kampinga MA, De Smet BJ, Tan ES, Van den Heuvel AF, Zijlstra F Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration. Trials 2009;10:90 Burzotta F, De Vita M, Gu YL, Isshiki T, Lefèvre T, Kaltoft A, Dudek D, Sardella G, Orrego PS, Antoniucci D, De Luca L, Biondi-Zoccai GG, Crea F, Zijlstra F Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis if 11 trials Eur Heart J 2009;30: Van t Hof AW, Zijlstra F The success of primary angioplasty: beyond TIMI flow summary of a presentation held at acute cardiac meeting in Paris, October 2008 Acute Card Care 2009; 11:66-8 Slart RH, Tio RA, Zijlstra F, Dierckx Diagnostic pathway of integrated SPECT/CT for coronary artery disease Eur J Nucl Med Mol Imaging 2009;36: Brands-Nijenhuis AV, Van Geel PP, Meijer K Acute myocardial ischemia in a patient with heterozygous alpha-2-plasmin inhibitor deficiency. Blood Coagul Firbrinolysis 2009; Moons P, Fleck D, Jaarsma T, Norekval TM, Smith K, Stromberg A, Thompson DR, Budts W; on behalf of the Undertaking Nursing Interventions Throughout Europe (UNITE) Study Group What do cardiovascular nurses know about the hematological management of patients with Eisenmenger syndrome? Eur J Cardiovasc Nurs 2009;11:1-9 Metra M, Teerlink JR, Voors AA, Felker GM, Milo-Cotter O, Weatherley B, Dittrich H, Cotter G Vasodilators in the treatment of acute heart failure: what we know, what we don t. Heart Fail Rev 2009;14:

14 Teichman SL, Unemori E, Dschietzig T, Conrad K, Voors AA, Teerlink JR, Felker GM, Metra M, Cotter G Relaxin, a pleiotropic vasodilator for the treatment of heart failure. Heart Fail Rev 2009;14:321-9 De Jong RM, Tio RA, Van der Harst P, Voors AA, Koning PM, Zeebregts CJ, Van Veldhuisen DJ, Dierckx RA, Slart RH Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy J Nucl Cardiol 2009;16: Damman K, Hillege HL, Van Veldhuisen DJ Albuminuria in heart failure: a CHARMing new risk factor? Lancet 2009;374:506-8 Groenveld HF, Crijns HJ, Rienstra M, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC; RACE Investigators Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study. Am Heart J 2009;158: Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, Van Veldhuisen DJ; COACH investigators Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 2009;11: Klapholz M, Abraham WT, Ghali JK, Ponikowski P, Anker SD, Knusel B, Sun Y, Wasserman SM, Van Veldhuisen DJ The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure. Eur J Heart Fail 2009;11: Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, Van Veldhuisen DJ, Brugada J; Scientific Committee; National Coordinators The European cardiac resynchronization therapy survey. Eur Heart J 2009;30: Van der Harst P, De Boer RA, Van Veldhuisen DJ The Nobel Prize for medicine for telomere biology and relevance to heart failure research. Eur J Heart Fail 2009;11: Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki L, Lindberg M, Ranjith N, Van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol 2009;54: Smit MD, Van Gelder IC Will we be able to predict in which atrial fibrillation patients a rhythm control strategy will be successful? Europace 2009;11:846-7

15 Van Veldhuisen DJ, Maass AH, Priori SG, Stoit P, Van Gelder IC, Dickstein K, Swedberg K Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillation) for patients with heart failure in Europe: changes from 2004 to Eur J Heart Fail 2009;11: Smit MD, Van Gelder IC Valsartan and recurrent atrial fibrillation. N Eng J Med 2009;30:532; author reply 533 Lesman-Leegte J, Van Veldhuisen DJ, Hillege HL, Moser D, Sanderman R, Jaarsma T Depressive symptoms and outcomes in patients with heart failure: data from the COACH study Eur J Heart Fail 2009;11: Van den Berg MP, Van Gelder IC New insight into the association among atrial fibrillation, electrophysiological remodelling, and the ACE insertion/deletion polymorphism-toward a more patient-tailored therapy? Heart Rhythm 2009;6: Van Tintelen JP, Van Gelder IC, Asimaki A, Suurmeijer AJ, Wiesfeld AC, Jongbloed JD, Van den Wijngaard A, Kuks JB, Van Spaendonck-Zwarts KY, Notermans N, Boven L, Van den Heuvel F, Veenstra-Knol HE, Saffitz JE, Hofstra RM, Van den Berg MP Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm 2009;6: Klinkenberg TJ, Ahmed S, Hagen AT, Wiesfeld AC, Tan ES, Zijlstra F, Van Gelder IC Feasibility and outcome of epicardial pulmonary vein isolation for lone atrial fibrillation using minimal invasive surgery and high intensity focused ultrasound. Europace 2009;11: Fokkema ML, Vlaar PJ, Vogelzang M, Gu YL, Kampinga MA, De Smet BJ, Jessurun GA, Anthonio RL, Van den Heuvel AF, Tan ES, Zijlstra F Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial. Circ Cardiovasc Intervent 2009;2:323-9 Nijveldt R, Van der Vleuten PA, Hirsch A, Beek AM, Tio RA, Tijssen JG, Piek JJ, Van Rossum AC, Zijlstra F Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size. JACC Cardiovasc Imaging 2009;2: Gu YL, Fokkema ML, Kampinga MA, De Smet BJ, Tan ES, Van den Heuvel AF, Zijlstra F Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration. Trials 2009;10:90 Bhuiyan ZA, Jopngbloed JD, Van der Smagt L, Lombardi PM, Wiesfeld AC, Nelen M, Schouten M, Jongbloed R, Cox MG, Van Wolferen M, Rodriguez LM, Van Gelder IC, Bikker H, Suurmeijer AJ, Van den Berg MP, Mannens MM, Hauer RN, Wilde AA, Van Tintelen JP Desmoglein-2 and desmocollin-2 mutations in Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy patients: results from a multicenter study.

16 Circ Cardiovasc Genet 2009;2: Lexis CP, Rahel BM, Meeder JG, Zijlstra F, Van der Horst IC The role of glucose lowering agents on restenosis after percutaneous coronary intervention for STelevation myocardial infarction. Cardiovasc Diabetol 2009;8:41 Moons P, Budts W, Costermans E, Huyghe E, Pieper PG, Drenthen W Pregnancy-related health behavior of women with congenital heart disease: room for behavioral change interventions. Congenit Heart Dis 2009;4: Muntinghe FL, Gross S, Bakker SJ, Landman GW, Van der Harst P, Bilo HJ, Navis G, Zuurman MW CCR5Delta32 genotype is accociated with outcome in type 2 diabetes mellitus. Diabetes Res Clin Pract 2009;86:140-5 Brands-Nijenhuis AV, Van Geel PP, Meijer K Acute myocardial ischemia in a patient with heterozygous alpha-2-plasmin inhibitor deficiency. Blood Coagul Fibrinolysis 2009;20: Bergstra A, Hoendermis ES, Talsma MD, Mook GA, Zijlstra WG, Berger RM Pulse densitometer indocyanine green dilution curves: a simple applicable and accurate method for determination of cardiac shunts. Congenit Heart Dis 2009;4:362-8 Bartels AL, Zeebregts CJ, Bijl M, Tio RA, Slart RH Fused FDG-PET and MRI imaging of Takayasu arteritis in vertebral arteries. Ann Nucl Med 2009;23:753-6 Vis JC, Thoonsen H, Duffels MG, De Bruin-Bon RA, Huisman SA, Van Dijk AP, Hoendermis ES, Berger RM, Bouma BJ, Mulder BJ Six-minute walk test in patients with Down syndrome: validity and reproducibility. Arch Phys Med Rehabil 2009;90: Duffels MG, Vis JC, Van Loon RL, Nieuwkerk PT, Van Dijk AP, Hoendermis ES, De Bruin-Bon RH, Bouma BJ, Bresser P, Berger RM, Mulder BJ Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down s syndrome. Am J Cardiol 2009;103: Yap SC, Drenthen W, Meijboom FJ, Moons P, Mulder BJ, Vliegen HW, Van Dijk AP, Jaddoe VW, Steegers EA, Roos-Hesselink JW, Pieper PG; ZAHARA investigators Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG 2009;116: Duffels MG, Hardziyenka M, Surie S, De Bruin-Bon RH, Hoendermis ES, Van Dijk AP, Bouma BJ, Tal HL, Berger RM, Bresser P, Mulder BJ Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension. Eur J Echocardogr 2009;10:433-8

17 Duffels MG, Vis JC, Van Loon RL, Berger RM, Hoendermis ES, Van Dijk AP, Bouma BJ, Mulder BJ Down patients with Eisenmenger syndrome: is bosentan treatment an option? Int J Cardiol 2009;134: De Jonge P, Rosmalen JG, Kema IP, Doornbos B, Van Melle JP, Pouwer F, Kupper N Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: A critical review of the literature. Neurosci Biobehav Rev 2009;

18 Nationale tijdschriften Jaarsma T A window of opportunity: improving cardiovascular health in women. Neth Heart J 2009;17:50-1 Broers CJM, Sinclair N, Van der Ploeg TJ, Jaarsma T, Van Veldhuisen DJ, Umans VAWM The post-infarction nurse practitioner project. A prospective study comparing nurse intervention with conventional care in a non-high-risk myocardial infarction population. Neth Heart Journal 2009;17:61-6 Nossent GD, Aerdts SJ, Kirkels JH, Van de Graaf EA, Van Kessel DA, Van den Bosh JM, Erasmus ME In Process Citation Ned Tijdschr Geneeskd 2009;153:623-7 Bögels PF, Beltman FW, Tio RA, Zijlstra F, Van der Meer K Telecardiologie bij ritmestoornissen in de huisartsenpraktijk. Een aanwinst? Hart Bulletin 2009;4:89-94 Hartog JWL, Willemsen S, Bakker SJL, Smit AJ, Voors AA, Van Veldhuisen De rol van advanced glycation end-products (AGE s) bij het ontstaan en de progressie van hart- en nierfalen. Ned Tijdschr Diabetol 2009;1:16-23 Pieper PG, Hamer JP 80-plussers met aortastenose. Ned Tijdschr Geneeskd 2009;153:270-1 Huzen J, Van Veldhuisen DJ, Van Gilst WH, Van der Harst P Telomeren en biologische veroudering bij hart- en vaatziekten. Ned Tijdschr Geneeskd 2009;152: Brugemann J, Van der Bij W, Verschuuren EA, Klungel AA, Van der Horst IC, Erasmus ME, Kerstjens HA, Van Veldhuisen DJ, Zijlstra F Ervaringen met gecombineerde hart-longtransplantatie in het Universitair Medisch Centrum Groningen. Ned Tijdschr Geneeskd 2009;153:B98 Van der Wall EE, De Boer MJ, Doevendans PA, Wilde AA, Zijlstra F Major achievements in cardiology in the past century: influence on Dutch cardiovascular medicine. Neth Heart J 2009;17:136-9 Mulder DJ, Van Haelst PL, Graaff R, Gans RO, Zijlstra F, Smit AJ Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events Neth Heart J 2009;17:162-8 Duffels MG, Van der Plas MN, Surie S, Winter MM, Bouma B, Groenink M, Van Dijk AP, Hoendermis E, Berger RM, Bresser P, Mulder BJ Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism. Neth Heart J 2009;17:334-8

19 Zuurmond-Tromp KA, Klinkenberg TJ, Dikkers FG, Koppelman GH, De Weerd W Severe dyspnoea in children following a fall. Ned Tijdschr Geneeskd 2009;153:A394 Tan ES, Mulder BA, Rienstra M, Wiesfeld AC, Ahmed S, Zijlstra F, Van Gelder IC Pulmonary vein isolation of symptomatic refractory paroxysmal and persistent atrial fibrillation: A single centre and single operator experience in the Netherlands Neth Heart J 2009;17: Kampinga MA, Vlaar PJ, Fokkema ML, Gu YL, Zijlstra F Thrombus aspiration during percutaneous coronary intervention in acute non-st-elevation myocardial infarction study (TAPASII)- study design Neth Heart J 2009;17: Tio RA, Slart RH, De Boer RA, Van der Vleuten PA, De Jong RM, Van Wiijk LM, Willems T, Lubbers DD, Voors AA, Van Veldhuisen DJ Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy. Neth Heart J 2009;17:470-4 Huijskes RV, Hoogenberg K, Wiesfeld AC, Pijl ME, Van Gelder IC Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report. Neth Heart J 2009;17: De Jong RM, Westerhof BE, Voors AA, Van Veldhuisen DJ Noninvasive haemodynamic monitoring using finger arterial pressure waveforms. Neth J Med 2009;67:372-5 Aalberts JJ, Boonstra PW, Van den Berg MP, Waterbolk TW In-hospital mortality and three-year survival after repaired acute type A aortic dissection. Neth Heart J 2009;17: Van Bockel EA, Lind JS, Zijlstra JG, Wijkstra PJ, Meijer PM, Van den Berg MP, Slart RH, Aarts LP, Tulleken JE Cardiac assessment of patients with late stage Duchenne muscular dystrophy. Neth Heart J 2009;17:232-7 Buck S, Maass AH, Van Veldhuisen DJ, Van Gelder IC Cardiac resynchronisation therapy and the role of optimal device utilisation. Neth Heart J 2009;17:354-7 Postema PG, Van den Berg MP, Van Tintelen JP, Van den Heuvel F, Grundeken M, Hofman N, Van der Roest WP, Nannenberg EA, Krapels LPC, Bezzina CR, Wilde AAM Founder mutations in the Netherlands. SCN5a 1895insD, the first described arrhythmia overlap syndrome and one of the largest and best characterized families worldwide. Neth Heart J 2009;17:422-8